tiprankstipranks
Jounce Therapeutics downgraded to Neutral from Overweight at Piper Sandler
PremiumThe FlyJounce Therapeutics downgraded to Neutral from Overweight at Piper Sandler
2y ago
Jounce Therapeutics implements workforce reduction of 84% of employees
Premium
The Fly
Jounce Therapeutics implements workforce reduction of 84% of employees
2y ago
Jounce to be acquired by Concentra for $1.85 in cash per share plus CVR
Premium
The Fly
Jounce to be acquired by Concentra for $1.85 in cash per share plus CVR
2y ago
Jounce Therapeutics confirms unsolicited proposal from Concentra Biosciences
PremiumThe FlyJounce Therapeutics confirms unsolicited proposal from Concentra Biosciences
2y ago
Jounce Therapeutics downgraded to Neutral from Outperform at SMBC Nikko
Premium
The Fly
Jounce Therapeutics downgraded to Neutral from Outperform at SMBC Nikko
2y ago
Jounce, Redx Pharma announce recommended all share merger transaction
Premium
The Fly
Jounce, Redx Pharma announce recommended all share merger transaction
2y ago
After-Hours Movers 
PremiumThe FlyAfter-Hours Movers 
2y ago
Gilead to buy remaining rights for GS-1811 from Jounce Therapeutics for $67M
Premium
The Fly
Gilead to buy remaining rights for GS-1811 from Jounce Therapeutics for $67M
2y ago
Jounce Therapeutics presents INNATE Phase 1, SELECT trial data
Premium
The Fly
Jounce Therapeutics presents INNATE Phase 1, SELECT trial data
2y ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100